$GHIX
Gores Holdings IX Inc

2022 Q4 Form 10-K Financial Statement

#000156459023003839 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $411.2K $1.631M
YoY Change 20058.33% 79834.8%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $411.2K $1.631M
YoY Change -98011.9% 26588.54%
Operating Profit -$1.631M
YoY Change
Interest Expense $4.436M $7.564M
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.133M $10.75M
YoY Change
Pretax Income $8.158M $16.68M
YoY Change 1942259.52% -273140.72%
Income Tax $579.7K $630.9K
% Of Pretax Income 7.11% 3.78%
Net Earnings $7.578M $16.05M
YoY Change 1804235.71% -262815.81%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.12 $0.25
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $378.1K $378.1K
YoY Change 156.91% 156.91%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $944.5K $944.5K
YoY Change 179.81% 179.81%
Inventory
Prepaid Expenses $944.5K
Receivables
Other Receivables
Total Short-Term Assets $1.323M $1.323M
YoY Change 172.85% 172.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $531.9M $531.9M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $531.9M $531.9M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.323M $1.323M
Total Long-Term Assets $531.9M $531.9M
Total Assets $533.3M $533.3M
YoY Change 109918.28% 109919.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $227.5K $227.5K
YoY Change 37.17% 37.17%
Deferred Revenue
YoY Change
Short-Term Debt $600.0K $600.0K
YoY Change 100.0% 100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $949.1K $949.1K
YoY Change 103.75% 103.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.908M $4.908M
YoY Change
Total Long-Term Liabilities $4.908M $4.908M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $949.1K $949.1K
Total Long-Term Liabilities $4.908M $4.908M
Total Liabilities $24.74M $24.74M
YoY Change 5211.46% 5211.41%
SHAREHOLDERS EQUITY
Retained Earnings -$22.52M
YoY Change 368316.7%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.52M $508.5M
YoY Change
Total Liabilities & Shareholders Equity $533.3M $533.3M
YoY Change 109918.28% 109919.19%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $7.578M $16.05M
YoY Change 1804235.71% -262815.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$93.13K -$2.514M
YoY Change -47.55% 1313.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$524.4M
YoY Change
Cash From Investing Activities $0.00 -$524.4M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 527.1M
YoY Change 162091.04%
NET CHANGE
Cash From Operating Activities -93.13K -2.514M
Cash From Investing Activities 0.000 -524.4M
Cash From Financing Activities 0.000 527.1M
Net Change In Cash -93.13K 230.9K
YoY Change -47.55% 56.91%
FREE CASH FLOW
Cash From Operating Activities -$93.13K -$2.514M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16682788
CY2022 ghix Threshold Number Of Period To Seek Shareholders Approval Prior To Consummation Of Business Combination To Redeem Their Shares
ThresholdNumberOfPeriodToSeekShareholdersApprovalPriorToConsummationOfBusinessCombinationToRedeemTheirShares
P2D
CY2022 ghix Threshold Number Of Period To Provide Opportunity To Shareholders To Sell Their Shares Prior To Consummation Of Business Combination
ThresholdNumberOfPeriodToProvideOpportunityToShareholdersToSellTheirSharesPriorToConsummationOfBusinessCombination
P2D
CY2022 ghix Number Of Possible Days For Winding Up
NumberOfPossibleDaysForWindingUp
P10Y
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41215
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23491
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6112
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
18888
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1593799
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
6260 Lookout Road
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Boulder
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80301
CY2022 dei City Area Code
CityAreaCode
303
CY2022 dei Local Phone Number
LocalPhoneNumber
531-3100
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
505575000
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York, New York, USA
CY2022Q4 us-gaap Cash
Cash
378072
CY2021Q4 us-gaap Cash
Cash
147160
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
944461
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
337544
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1322533
CY2021Q4 us-gaap Assets Current
AssetsCurrent
484704
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
531940494
CY2022Q4 us-gaap Assets
Assets
533263027
CY2021Q4 us-gaap Assets
Assets
484704
CY2022Q4 ghix Accrued Expenses Formation And Offering Costs
AccruedExpensesFormationAndOfferingCosts
27446
CY2021Q4 ghix Accrued Expenses Formation And Offering Costs
AccruedExpensesFormationAndOfferingCosts
161746
CY2022Q4 ghix Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
200000
CY2021Q4 ghix Accrual For State Franchise Taxes Current
AccrualForStateFranchiseTaxesCurrent
4070
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
121667
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
600000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
300000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
949113
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
465816
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
509185
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
18375000
CY2021Q4 us-gaap Liabilities
Liabilities
465816
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
484704
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 ghix Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
1430672
ghix Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
2042
ghix Professional Fees And Other Expenses
ProfessionalFeesAndOtherExpenses
2042
CY2022 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
200000
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
4070
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
4070
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1630672
us-gaap Operating Income Loss
OperatingIncomeLoss
-6112
us-gaap Operating Income Loss
OperatingIncomeLoss
-6112
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11366667
CY2022 ghix Issuance Costs Related To Warrant Liability
IssuanceCostsRelatedToWarrantLiability
617225
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
7564018
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16682788
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6112
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
630852
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
630852
CY2022 us-gaap Net Income Loss
NetIncomeLoss
16051936
CY2022 us-gaap Net Income Loss
NetIncomeLoss
16051936
us-gaap Net Income Loss
NetIncomeLoss
-6112
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
18888
CY2022 ghix Adjustments To Additional Paid In Capital Excess Of Fair Value Paid By Founders For Warrants
AdjustmentsToAdditionalPaidInCapitalExcessOfFairValuePaidByFoundersForWarrants
7250000
CY2022 ghix Adjustments To Additional Paid In Capital For Subsequent Measurement Of Common Stock Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalForSubsequentMeasurementOfCommonStockSubjectToRedemption
7273688
CY2022 ghix Subsequent Measurement Of Common Stock Subject To Redemption Against Accumulated Deficit
SubsequentMeasurementOfCommonStockSubjectToRedemptionAgainstAccumulatedDeficit
32525740
CY2022 us-gaap Net Income Loss
NetIncomeLoss
16051936
CY2022 ghix Increase In Redemption Value Of Common Stock Subject To Redemption
IncreaseInRedemptionValueOfCommonStockSubjectToRedemption
-6037712
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22516316
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
18888
CY2022 us-gaap Profit Loss
ProfitLoss
16051936
us-gaap Profit Loss
ProfitLoss
-6112
CY2022 ghix Issuance Costs Related To Warrant Liability
IssuanceCostsRelatedToWarrantLiability
617225
CY2022 ghix Dividends Reinvested In Trust Account
DividendsReinvestedInTrustAccount
7564018
CY2022 ghix Increase Decrease In Accrued Expenses Formation And Offering Costs Current
IncreaseDecreaseInAccruedExpensesFormationAndOfferingCostsCurrent
-134300
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2513503
CY2022 ghix Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
525000000
CY2022 ghix Cash Withdrawn From Trust Account For Tax And Regulatory Expenses
CashWithdrawnFromTrustAccountForTaxAndRegulatoryExpenses
623524
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-524376476
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
525000000
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
12500000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
600000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
325000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
147160
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.       Organization and Business Operations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Organization and General</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gores Holdings IX, Inc. (the “Company”) was incorporated in Delaware on January 19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). The Company has neither engaged in any operations nor generated any revenue to date. The Company’s management has broad discretion with respect to the Business Combination. The Company’s Sponsor is Gores Sponsor IX, LLC, a Delaware limited liability company (the “Sponsor”). The Company has selected December 31st as its fiscal year-end.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2022, the Company had not commenced any operations. All activity for the Period from January 19, 2021 (inception) through January 13, 2022 relates to the Company’s formation and initial public offering (“Public Offering”) described below. The Company subsequently completed the Public Offering on January 14, 2022 (the “IPO Closing Date”). The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. Subsequent to the Public Offering, the Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering and the sale of the Private Placement Warrants (as defined below) held in the Trust Account (as defined below).</p> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:7.42%;">Financing</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the IPO Closing Date and the sale of the Private Placement Warrants, an aggregate of $525,000,000 was placed in a Trust Account with Deutsche Bank Trust Company Americas (the “Trust Account”) acting as Trustee. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company intends to finance a Business Combination with the net proceeds from its $525,000,000 Public Offering and its sale of $12,500,000 of Private Placement Warrants.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trust Account</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funds held in the Trust Account can be invested only in U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less or in money market funds meeting certain conditions under Rule 2a‑7 under the Investment Company Act that invest only in direct U.S. government obligations. As of December 31, 2022, the Trust Account consisted of money market funds.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to fund regulatory compliance requirements and other costs related thereto (a “Regulatory Withdrawal”) for a maximum 24 months and/or additional amounts necessary to pay franchise and income taxes, if any, none of the funds held in trust will be released until the earliest of: (i) the completion of the Business Combination; or (ii) the redemption of any public shares of common stock properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of such public shares of common stock if the Company does not complete the Business Combination within 24 months from the closing of the Public Offering; or (iii) the redemption of 100% of the public shares of common stock if the Company is unable to complete a Business Combination within 24 months from the closing of the Public Offering, subject to the requirements of law and stock exchange rules.</p> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:7.42%;">Business Combination</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination. The Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest income earned) at the time of the Company signing a definitive agreement in connection with the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable, or (ii) provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest income but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval, unless a vote is required by law or under Nasdaq rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. Currently, the Company will not redeem its public shares of common stock in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its public shares of common stock and the related Business Combination, and instead may search for an alternate Business Combination.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the foregoing redemption provisions, the public shares of common stock will be recorded at redemption amount and classified as temporary equity, in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”) in subsequent periods.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will have 24 months from the IPO Closing Date to complete its Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of common stock for a per share pro rata portion of the Trust Account, including interest income, but less taxes payable (less up to $100,000 of such net interest income to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they waived their rights to participate in any redemption with respect to their Founder Shares (as defined below); however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire public shares of common stock, they will be entitled to a pro rata share of the Trust Account in the event the Company does not complete a Business Combination within the required time period.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.</p> <p style="text-align:left;margin-bottom:0pt;margin-top:12pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:7.42%;">Emerging Growth Company</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section 102(b)(1) of the Jumpstart Our Business Startup (“JOBS”) Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</p>
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-19
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
525000000
CY2022 ghix Regulatory Withdrawal Of Interest From Trust Account Maximum Period
RegulatoryWithdrawalOfInterestFromTrustAccountMaximumPeriod
P24M
CY2022Q4 ghix Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2022 ghix Dissolution Expenses Maximum Allowed
DissolutionExpensesMaximumAllowed
100000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution as well as the Trust Account, which throughout the year regularly exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</p>
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
137507
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1503
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1503
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
137507
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
29391653
CY2022 ghix Underwriters Fee
UnderwritersFee
28875000
CY2022 ghix Issuance Costs Related To Warrant Liability
IssuanceCostsRelatedToWarrantLiability
617225
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p>
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
630852
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
55670
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1370
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2022Q4 ghix Percentage Of Redemption If Business Combination Not Completed
PercentageOfRedemptionIfBusinessCombinationNotCompleted
1
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
0
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
531940494
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
81837
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
133
CY2022 ghix Going Concern Description
GoingConcernDescription
In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” we have until January 14, 2024 to consummate a Business Combination. It is uncertain that we will be able to consummate a Business Combination by this time. If the Company does not complete its Business Combination by January 14, 2024, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the common stock sold as part of the units in the Public Offering, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of franchise and income taxes payable and less up to $100,000 of such net interest which may be distributed to the Company to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
CY2022 ghix Common Stock Redemption Percentage
CommonStockRedemptionPercentage
1
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
949113
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
465816
CY2022Q4 ghix Working Capital Deficit
WorkingCapitalDeficit
373420
CY2021Q4 ghix Working Capital Deficit
WorkingCapitalDeficit
-318656
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
525000000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3503385
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1284
CY2022 ghix Income Tax Reconciliation Warrant Liability
IncomeTaxReconciliationWarrantLiability
2387000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2310
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-220
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
129617
CY2022 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
615965
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1496
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1504
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
630852
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
121667
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
121667
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
507087
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2098
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
509185
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
231166
CY2022Q4 ghix Deferred Tax Liabilities Accrued Income
DeferredTaxLiabilitiesAccruedIncome
415526
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
646692
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
509185
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 ghix Effective Income Tax Rate Reconciliation Facilitative Expenses Percent
EffectiveIncomeTaxRateReconciliationFacilitativeExpensesPercent
0.000
CY2021 ghix Effective Income Tax Rate Reconciliation Facilitative Expenses Percent
EffectiveIncomeTaxRateReconciliationFacilitativeExpensesPercent
0.000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.008
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000
CY2022 ghix Effective Income Tax Rate Reconciliation Warrant Liability Percent
EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent
0.143
CY2021 ghix Effective Income Tax Rate Reconciliation Warrant Liability Percent
EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent
0.000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
0.037
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
0.000
CY2022 ghix Effective Income Tax Rate Reconciliation Change In State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInStateTaxRatePercent
0.000
CY2021 ghix Effective Income Tax Rate Reconciliation Change In State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInStateTaxRatePercent
0.036
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.038
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2022Q4 ghix Number Of Votes For Each Share
NumberOfVotesForEachShare
1
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
52500000
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0

Files In Submission

Name View Source Status
0001564590-23-003839-index-headers.html Edgar Link pending
0001564590-23-003839-index.html Edgar Link pending
0001564590-23-003839.txt Edgar Link pending
0001564590-23-003839-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ghix-10k_20221231.htm Edgar Link pending
ghix-20221231.xsd Edgar Link pending
ghix-ex311_6.htm Edgar Link pending
ghix-ex312_7.htm Edgar Link pending
ghix-ex321_8.htm Edgar Link pending
ghix-ex322_9.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ghix-20221231_def.xml Edgar Link unprocessable
ghix-20221231_cal.xml Edgar Link unprocessable
ghix-20221231_lab.xml Edgar Link unprocessable
ghix-20221231_pre.xml Edgar Link unprocessable
ghix-10k_20221231_htm.xml Edgar Link completed